1WHO Global surveillance and control of hepatitis C.Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board,Antwerp,Belgium.J Viral Hepat 1999; 6:35-47 被引量：1
3Villano SA,Vlahov D,Nelson KE,et al.Incidence and risk factors for hepatitis C among injection drug users in Baltimore,Maryland.J Clin Microbiol 1997; 35:3274-3277 被引量：1
4田兆嵩主编..临床输血学[M].北京:人民卫生出版社,1998:297.
5Halfon P,Khiri H,Feryn JM,et al.Prospective virolocial follow up of hepatitis C infection in a haemodialysis unit.J Viral Hepat 1998; 5:115-121 被引量：1
6Forns X,Fernandez-Llama P,Pons M,et al.Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit.Nephrol Dial Transplant 1997; 12:736-740 被引量：1
7Fabrizi F,Martin P,Dixit V,et al.Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients.Am J Nephrol 1999; 19:383-388 被引量：1
8Weiner A J,Thaler MM,Crawford K.J Virol,1993,67(7):4365 被引量：1
10Thomas DA,Villano SA,Riester KA,et al.Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers:women and infants transmission study.J Infect Dis 1998; 177:1480-1488 被引量：1
2Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol, 2003, 36:47-53. 被引量：1
3WHO Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, antwerp, belgium. J Viral Hepat,1999, 6:35-47. 被引量：1
4Armstrong GL, Alter MJ, MeQuillan GM, et al. The past incidence of hepatitis C virus infection: implications for the future burden of ehronle liver disease in the United States. Hepatology,2000, 31:777-782. 被引量：1
5Alter MJ, Kruszon-Moran D, Nainan OV, et al. Prevalence of hepatitis C virus infection in the United States, 1988-1994. N Engl J Med, 1999, 341:556-562. 被引量：1
6Lowe D, Cotton R. Hepatitis C: a review of Australia's response. Publications Production Unit, Commonwealth department of health and aged care, Commonwealth of Australia, Canberra, 1999. 被引量：1
7Villano SA, Vlahov D, Nelson KE, et al. Incidence and risk factors for hepatitis C among injection drug users in Baltimore,Maryland. J Clin Microbiol, 1997, 35: 3274-3277. 被引量：1
8Hollinger FB, Kirtava A, Oakley M, et al. Blood safety monitoring among patients with bleeding disorders-United States, May1998-June, 2002. MMWR, 2003,1152-1154. 被引量：1
9Takano S, Nakamura K, Kawai S, et al. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first-and second-generation assays as a means of preventing posttransfusion hepatitis. Hepatology, 1996,23:708-712. 被引量：1
10Gonzalez A, Esteban JI, Madoz P, et al. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis:final report of a prospective trial. Hepatology, 1995,22:439-445. 被引量：1
